MannKind Corp has a consensus price target of $7.6 based on the ratings of 5 analysts. The high is $10 issued by Wedbush on October 10, 2023. The low is $6 issued by SVB Leerink on November 9, 2022. The 3 most-recent analyst ratings were released by Rodman & Renshaw, Cantor Fitzgerald, and Cantor Fitzgerald on June 13, 2024, May 9, 2024, and March 15, 2024, respectively. With an average price target of $7 between Rodman & Renshaw, Cantor Fitzgerald, and Cantor Fitzgerald, there's an implied 21.63% upside for MannKind Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/13/2024 | Buy Now | 39.01% | Rodman & Renshaw | Brandon Folkes | → $8 | Initiates | → Buy | Get Alert |
05/09/2024 | Buy Now | 12.95% | Cantor Fitzgerald | Olivia Brayer | → $6.5 | Reiterates | Overweight → Overweight | Get Alert |
03/15/2024 | Buy Now | 12.95% | Cantor Fitzgerald | Olivia Brayer | — | Reiterates | Overweight → Overweight | Get Alert |
02/28/2024 | Buy Now | 12.95% | Cantor Fitzgerald | Olivia Brayer | → $6.5 | Reiterates | Overweight → Overweight | Get Alert |
01/04/2024 | Buy Now | 30.32% | HC Wainwright & Co. | Oren Livnat | → $7.5 | Reiterates | Buy → Buy | Get Alert |
10/10/2023 | Buy Now | 73.76% | Wedbush | Andreas Argyrides | → $10 | Initiates | → Outperform | Get Alert |
08/14/2023 | Buy Now | 30.32% | HC Wainwright & Co. | Oren Livnat | $7 → $7.5 | Maintains | Buy | Get Alert |
08/08/2023 | Buy Now | 30.32% | Cantor Fitzgerald | Olivia Brayer | $6.5 → $7.5 | Maintains | Overweight | Get Alert |
05/11/2023 | Buy Now | 21.63% | HC Wainwright & Co. | Oren Livnat | → $7 | Reiterates | Buy → Buy | Get Alert |
02/27/2023 | Buy Now | 21.63% | HC Wainwright & Co. | Oren Livnat | $6 → $7 | Maintains | Buy | Get Alert |
11/09/2022 | Buy Now | 4.26% | SVB Leerink | Thomas Smith | $5 → $6 | Maintains | Outperform | Get Alert |
02/28/2022 | Buy Now | 4.26% | HC Wainwright & Co. | Oren Livnat | $6.5 → $6 | Maintains | Buy | Get Alert |
The latest price target for MannKind (NASDAQ:MNKD) was reported by Rodman & Renshaw on June 13, 2024. The analyst firm set a price target for $8.00 expecting MNKD to rise to within 12 months (a possible 38.89% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for MannKind (NASDAQ:MNKD) was provided by Rodman & Renshaw, and MannKind initiated their buy rating.
There is no last upgrade for MannKind
There is no last downgrade for MannKind.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MannKind, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MannKind was filed on June 13, 2024 so you should expect the next rating to be made available sometime around June 13, 2025.
While ratings are subjective and will change, the latest MannKind (MNKD) rating was a initiated with a price target of $0.00 to $8.00. The current price MannKind (MNKD) is trading at is $5.76, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.